Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
112.1 EUR | -0.18% | +3.14% | +3.61% |
Apr. 24 | IPSEN : Better-than-expected Q1; guidance unchanged | |
Apr. 24 | Transcript : Ipsen S.A., Q1 2024 Sales/ Trading Statement Call, Apr 24, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.61% | 9.94B | |
+24.17% | 556B | |
-6.33% | 354B | |
+19.90% | 331B | |
+7.95% | 296B | |
+13.45% | 233B | |
+6.04% | 201B | |
-10.51% | 193B | |
-12.26% | 143B | |
-6.47% | 144B |
- Stock Market
- Equities
- IPN Stock
- News Ipsen
- Ipsen : to Focus on Oncology, Rare Disease and Neuroscience; Sales Poised to Grow Up to 5% Through 2024